Equities
Health CarePharmaceuticals and Biotechnology
  • Price (AUD)279.18
  • Today's Change2.13 / 0.77%
  • Shares traded485.38k
  • 1 Year change-7.92%
  • Beta0.4659
Data delayed at least 20 minutes, as of May 10 2024 07:10 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Jun 30 2023202320222021
OPERATIONS
Net income2,6632,7802,963
Depreciation/depletion831668590
Non-Cash items675648545
Cash taxes paid, supplemental563457495
Cash interest paid, supplemental374172161
Changes in working capital(1568)(1467)(475)
Total cash from operations2,6012,6293,622
INVESTING
Capital expenditures(1692)(1248)(1667)
Other investing and cash flow items, total(10151)(388)(6.1)
Total cash from investing(11843)(1636)(1673)
FINANCING
Financing cash flow items(154)2.50(3.5)
Total cash dividends paid(1085)(1039)(958)
Issuance (retirement) of stock, net344,98856
Issuance (retirement) of debt, net1,6613,724(497)
Total cash from financing4567,676(1402)
NET CHANGE IN CASH
Foreign exchange effects(39)(64)32
Net change in cash(8825)8,604579
Net cash-begin balance/reserved for future use10,3341,7301,151
Net cash-end balance/reserved for future use1,50910,3341,730
SUPPLEMENTAL INCOME
Depreciation, supplemental831668590
Cash interest paid, supplemental374172161
Cash taxes paid, supplemental563457495
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.